Phase 1 human trials of a Canadian Ebola vaccine are beginning today.

The problem with new vaccines (and antibiotics) is that they are expensive to create and test with no certain payback for the investment. These sort of public goods mostly rely on government funding which tends to be insufficient when the threat is perceived to be low and inefficiently allocated when the threat is perceived to be high.

We sure cured erectile dysfunction.